Goldman Sachs Group Inc Takeda Pharmaceutical CO LTD Put Options Transaction History
Goldman Sachs Group Inc
- $555 Billion
- Q1 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding TAK
# of Institutions
341Shares Held
76MCall Options Held
1.85MPut Options Held
121K-
Capital Research Global Investors Los Angeles, CA13.1MShares$171 Million0.04% of portfolio
-
Mondrian Investment Partners LTD London, X012.1MShares$157 Million2.47% of portfolio
-
Morgan Stanley New York, NY5MShares$65.1 Million0.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny3.12MShares$40.6 Million0.07% of portfolio
-
Brandes Investment Partners, LP La Jolla, CA2.9MShares$37.8 Million0.54% of portfolio
About TAKEDA PHARMACEUTICAL CO LTD
- Ticker TAK
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 3,109,050,112
- Market Cap $40.5B
- Description
- Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...